LETERMOVIR

UNII:	1H09Y5WO1F
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₉H₂₈F₄N₄O₄
Preferred Substance Name:	LETERMOVIR
InChIKey:	FWYSMLBETOMXAG-QHCPKHFHSA-N
GSRS Full Record:	1H09Y5WO1F i

917389-32-3
(4S)-2-{8-Fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid
2-((4S)-8-Fluoro-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4h-quinazolin-4-yl)acetic acid
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-, (4S)-
AIC-246
AIC246
Letermovir
Letermovir [INN]
Letermovir [JAN]
Letermovir [MI]
Letermovir [ORANGE BOOK]
Letermovir [USAN]
Letermovir [WHO-DD]
MK-8228
Prevymis

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LETERMOVIR

Synonyms and Mappings

Resources